XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Cash flows from operating activities:          
Net income $ 4,551 $ 1,798 $ 7,741 $ 2,223  
Adjustments to reconcile net income to net cash (used in) provided by operating activities:          
Depreciation and amortization     2,207 2,250  
Amortization of marketable securities premium     81 75  
Impairment charge on equity investee       313  
Stock-based compensation     931 622  
Realized gain on sale of available-for-sale securities       (77)  
Gain on disposal of equipment     (13) (1)  
Loss from equity method investments, net     27 808  
Changes in operating assets and liabilities:          
Accounts receivable     61 (3,683)  
Inventories     (11,923) (119)  
Prepaid expenses and other current assets     (2,075) (264)  
Other assets     59 (28)  
Accounts payable     2,833 1,368  
Accrued liabilities [1]     (414) 21  
Other long-term liabilities, including royalties     24 (302)  
Net cash (used in) provided by operating activities     (461) 3,206  
Cash flows from investing activities:          
Purchases of property, plant and equipment     (21,920) (1,831)  
Proceeds from sale of equipment     11    
Purchases of available-for-sale securities     (9,936) (23,763)  
Proceeds from sales and maturities of available-for-sale securities     17,870 10,170  
Repayment of related party notes receivable       53  
Net cash used in investing activities     (13,975) (15,371)  
Cash flows from financing activities:          
Proceeds from issuance of common stock and options exercised, net of issuance costs     178 32,746  
Considerations paid in cash to repurchase subsidiary shares from noncontrolling interest     (163)    
Dividends paid by joint ventures to their minority shareholders       (465)  
Net cash provided by financing activities     15 32,281  
Effect of exchange rate changes on cash and cash equivalents     (233) 215  
Net increase (decrease) in cash and cash equivalents     (14,654) 20,331  
Cash and cash equivalents at the beginning of the period     44,352 36,152 $ 36,152
Cash and cash equivalents at the end of the period $ 29,698 $ 56,483 29,698 $ 56,483 $ 44,352
Supplemental disclosure of non-cash flow information:          
Consideration payable to repurchase subsidiary shares from noncontrolling interests, included in accrued liabilities     1,192    
Reduction of noncontrolling interests in excess of total consideration paid and payable in connection with the repurchase of subsidiaries shares from noncontrolling interests     $ 196    
[1] * Dividend accrued but not paid by one of our consolidated subsidiaries of $524 and $512 was included in accrued liabilities as of June 30, 2018 and 2017, respectively.